Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Enamine and Exquiron Announces Multiyear Collaboration

Published: Monday, June 03, 2013
Last Updated: Monday, June 03, 2013
Bookmark and Share
Enamine provides Exquiron with large novel diverse screening compound library.

Enamine Ltd and Exquiron Biotech AG have announced a multiyear collaboration under which Enamine will provide a carefully selected, novel diverse screening compound library.

This library will be made available by Exquiron to screening clients for hit discovery projects.

The library provided by Enamine is a great asset for discovery programs as it includes a high number of diverse drug-like compounds.

Exquiron and its clients will also have access to Enamine’s full range of chemistry expertise, for post screening follow-up.

Dr. Serge Parel, VP Chemistry and Research Informatics, Exquiron, commented: “Offering high quality chemistry to our clients is crucial. We are impressed by the quality and novelty of Enamine’s compounds, coupled with their logistics and support services. Together we can offer clients excellent value.”

“We are pleased that Exquiron has chosen to work with us. We see this as confirmation of the quality of our chemistry and services, and hope that our collaboration will contribute to Exquiron’s success,” added Michael Bossert, Head of Strategic Alliances, Enamine.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Enamine Announces Extension of Collaboration with Sanofi in Early Drug Discovery
Sanofi continue to access Enamine’s in-house designed and synthesized screening compound library.
Friday, December 19, 2014
Enamine Provides Large Novel Diverse Compound Screening Library To BioFocus
The company announced it has extended its long-standing relationship with BioFocus. The library will be available to BioFocus HTS collaborators in early 2012.
Wednesday, February 01, 2012
Scientific News
Tumor Markers Reveal Lethality Of Bladder Cancers
Researchers found that detection of certain tumor cells in early stage cancers helps identify high-risk cancers.
Drug Target for Triple-Negative Breast Cancer Found
A team of researchers led by UC San Francisco scientists has identified a new drug target for triple-negative breast cancer.
Smartphone Laboratory Detects Cancer
Researchers develop low-cost, portable laboratory on a smartphonecapable of analysing multiple samples simultaneously.
First Entirely 3D-printed Organ-on-a-Chip with Integrated Sensors
New approach to manufacturing may allow researchers to rapidly design organs-on-chips that match the properties of a specific disease or individual patient's cells.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
Bacterial Genes Boost Current in Human Cells
Borrowing and tweaking bacterial genes to enhance electrical activity might treat heart, nervous system injury.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
Cocoa Compound Linked to Some Cardiovascular Biomarker Improvements
The study highlights the urgent need for large, long-term RCTs that improve understanding of how the short-term benefits of cocoa flavanol intake on cardiometabolic biomarkers may be translated into clinical outcomes.
Untangling a Cause of Memory Loss in Neurodegenerative Diseases
The mouse study identifies a possible therapeutic target for a family of disorders.
New Pathway for COPD Biomarker Development
A study from Philip Morris International has highlighted multi-lipid profiling as a potential new pathway for COPD biomarker development.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos